Commonwealth Equity Services’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Sell |
36,543
-9,500
| -21% | -$111K | ﹤0.01% | 3288 |
|
|
2025
Q1 | $342K | Buy |
46,043
+415
| +0.9% | +$3.08K | ﹤0.01% | 3379 |
|
|
2024
Q4 | $274K | Buy |
45,628
+50
| +0.1% | +$300 | ﹤0.01% | 3498 |
|
|
2024
Q3 | $233K | Sell |
45,578
-50
| -0.1% | -$256 | ﹤0.01% | 3565 |
|
|
2024
Q2 | $165K | Sell |
45,628
-333
| -0.7% | -$1.2K | ﹤0.01% | 3695 |
|
|
2024
Q1 | $148K | Sell |
45,961
-327
| -0.7% | -$1.05K | ﹤0.01% | 3715 |
|
|
2023
Q4 | $227K | Sell |
46,288
-8,976
| -16% | -$44K | ﹤0.01% | 3405 |
|
|
2023
Q3 | $301K | Buy |
55,264
+3,498
| +7% | +$19.1K | ﹤0.01% | 3033 |
|
|
2023
Q2 | $347K | Buy |
51,766
+1,800
| +4% | +$12.1K | ﹤0.01% | 2922 |
|
|
2023
Q1 | $441 | Sell |
49,966
-5,035
| -9% | -$44 | ﹤0.01% | 2663 |
|
|
2022
Q4 | $420K | Buy |
55,001
+1,300
| +2% | +$9.93K | ﹤0.01% | 2608 |
|
|
2022
Q3 | $382K | Buy |
53,701
+1,225
| +2% | +$8.71K | ﹤0.01% | 2626 |
|
|
2022
Q2 | $424K | Sell |
52,476
-1,390
| -3% | -$11.2K | ﹤0.01% | 2537 |
|
|
2022
Q1 | $747K | Buy |
53,866
+6,701
| +14% | +$92.9K | ﹤0.01% | 2215 |
|
|
2021
Q4 | $1.32M | Sell |
47,165
-14,901
| -24% | -$418K | ﹤0.01% | 1792 |
|
|
2021
Q3 | $2.11M | Sell |
62,066
-2,743
| -4% | -$93.2K | 0.01% | 1397 |
|
|
2021
Q2 | $2.65M | Buy |
64,809
+22,653
| +54% | +$926K | 0.01% | 1244 |
|
|
2021
Q1 | $1.7M | Sell |
42,156
-225
| -0.5% | -$9.06K | ﹤0.01% | 1442 |
|
|
2020
Q4 | $2.51M | Sell |
42,381
-894
| -2% | -$52.8K | 0.01% | 1099 |
|
|
2020
Q3 | $2.1M | Buy |
43,275
+1,116
| +3% | +$54.3K | 0.01% | 1067 |
|
|
2020
Q2 | $2.04M | Buy |
42,159
+36
| +0.1% | +$1.74K | 0.01% | 1020 |
|
|
2020
Q1 | $1.17M | Buy |
+42,123
| New | +$1.17M | 0.01% | 1178 |
|